内部人交易雷达

美国 · SEC Form 4 · 快照日期： 2026-10-18 · 构建时间： 2026-10-18 · English

← 美国市场 · 覆盖记录

美国 · SEC FORM 4

Neurogene Inc.

NGNE · Nasdaq · CIK 0001404644 · Healthcare · Biotechnology

内部人信号

当前没有活跃买入信号

0 qualifying P purchase groups
当前 180 天评分窗口

8 同一窗口内观察到的 Form 4 交易行
7 sales · 1 期权、代扣税、授予、赠与或其他交易行

最近一次合资格买入2024-11-26 · AKKARAJU SRINIVAS; Samsara BioCapital GP, LLC; Samsara BioCapital, L.P. · $1.3M

为什么没有活跃信号？

买入活动无
近期买入无
近期卖出中等
买入信号状态未激活
评分构成

活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。

Cluster未计算
买入规模未计算
角色未计算
近期性未计算
确信度未计算

为什么没有分数？

  • 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
  • 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。

卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。

内部人活动时间轴

申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。

AprMayJunJulAugSepOct
Cvijic Christine MikailPresident and CFO
▼▼▼▼▼
McMinn RachelChief Executive Officer
○
● 买入▼ 卖出○ 其他

—

买方广度、集中度与聚集买入

合资格买入进入 180 天研究窗口后，这些模块才会启用。

信号历史

暂无已记录的活跃信号快照

Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2024-11-26 · AKKARAJU SRINIVAS; Samsara BioCapital GP, LLC; Samsara BioCapital, L.P..

近期 Form 4 活动

0买入
17卖出
5其他 Form 4 交易行
14SEC 申报 · 365天
买入0 qualifying P line(s) · 180 days
卖出7 sale line(s) · 仅供背景
其他1 exercise / withholding / award / gift / other lines
10b5-1／计划交易Not assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

市场背景

该股票尚未获取市场背景。每日任务会轮转处理美国股票池。

空头余额

空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。

空头股数
4,974,749
上期报告
3,280,172
日均成交量
423,989
回补天数
11.7

FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。

历史股票买入

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting owner类型证券股数平均价格估算金额来源
2024-11-26AKKARAJU SRINIVAS; Samsara BioCapital GP, LLC; Samsara BioCapital, L.P.买入 (P)Common Stock48,770USD 25.83USD 1,259,623SEC 申报 ↗
2024-11-22McMinn Rachel买入 (P)Common Stock47,500USD 20.40USD 969,000SEC 申报 ↗
2024-11-22Cvijic Christine Mikail买入 (P)Common Stock24,000USD 20.48USD 491,520SEC 申报 ↗
2023-08-17667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP买入 (P)Common Stock166,942USD 0.69USD 115,190SEC 申报 ↗
2023-08-16667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP买入 (P)Common Stock229,600USD 0.68USD 156,128SEC 申报 ↗
2023-08-15667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP买入 (P)Common Stock1,888,800USD 0.63USD 1,190,132SEC 申报 ↗
2021-08-25DRACHMAN JONATHAN G买入 (P)Common Stock25,000USD 6.45USD 161,250SEC 申报 ↗
2021-08-24DRACHMAN JONATHAN G买入 (P)Common Stock100,000USD 6.11USD 611,000SEC 申报 ↗
2021-06-04DRACHMAN JONATHAN G买入 (P)Common Stock10,000USD 9.61USD 96,100SEC 申报 ↗
2021-06-03DRACHMAN JONATHAN G买入 (P)Common Stock40,000USD 9.48USD 379,200SEC 申报 ↗
2020-07-07667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP买入 (P)Common Stock424,000USD 15.25USD 6,466,000SEC 申报 ↗
2020-04-02Green Jeremy; Redmile Group, LLC买入 (P)Common Stock39,300USD 11.37USD 446,938SEC 申报 ↗
2020-04-01Green Jeremy; Redmile Group, LLC买入 (P)Common Stock42,500USD 11.10USD 471,675SEC 申报 ↗
2020-03-31Green Jeremy; Redmile Group, LLC买入 (P)Common Stock30,000USD 10.31USD 309,375SEC 申报 ↗
2020-03-30Green Jeremy; Redmile Group, LLC买入 (P)Common Stock32,500USD 9.94USD 323,047SEC 申报 ↗

Form 4 申报证据

22 transaction lines in the latest 365-day window; 110 in local history.

日期申报人类型证券股数平均价格估算金额来源
2026-09-22McMinn Rachel期权行权／转换 (M)Common Stock756USD 25.32USD 19,142SEC 申报 ↗
2026-07-07Cvijic Christine Mikail卖出 (S)Common Stock4,200USD 36.13USD 151,746SEC 申报 ↗
2026-07-06Cvijic Christine Mikail卖出 (S)Common Stock600USD 36.02USD 21,612SEC 申报 ↗
展开近期 Form 4 证据 (16 grouped rows)
日期申报人类型证券股数平均价格估算金额来源
2026-09-22McMinn Rachel期权行权／转换 (M)Common Stock756USD 25.32USD 19,142SEC 申报 ↗
2026-07-07Cvijic Christine Mikail卖出 (S)Common Stock4,200USD 36.13USD 151,746SEC 申报 ↗
2026-07-06Cvijic Christine Mikail卖出 (S)Common Stock600USD 36.02USD 21,612SEC 申报 ↗
2026-07-02Cvijic Christine Mikail卖出 (S)Common Stock4,061USD 34.82USD 141,424SEC 申报 ↗
2026-07-01Cvijic Christine Mikail卖出 (S)Common Stock739USD 34.06USD 25,170SEC 申报 ↗
2026-05-06Cvijic Christine Mikail卖出 (S)Common Stock9,600USD 31.25USD 300,048SEC 申报 ↗
2026-03-26McMinn Rachel卖出 (S)Common Stock3,352USD 22.07USD 73,979SEC 申报 ↗
2026-03-26Jordan Julie卖出 (S)Common Stock828USD 21.89USD 18,125SEC 申报 ↗
2026-03-26Cvijic Christine Mikail卖出 (S)Common Stock2,558USD 21.62USD 55,304SEC 申报 ↗
2026-03-13Cvijic Christine Mikail卖出 (S)Common Stock4,045USD 20.81USD 84,178SEC 申报 ↗
2026-03-13Cobb Stuart卖出 (S)Common Stock6,797USD 20.81USD 141,446SEC 申报 ↗
2026-02-27Cvijic Christine Mikail卖出 (S)Common Stock4,800USD 25.11USD 120,528SEC 申报 ↗
2026-02-20McMinn Rachel奖励／授予 (A)Common Stock25,900USD 0.00USD 0SEC 申报 ↗
2026-02-20Jordan Julie奖励／授予 (A)Common Stock4,900USD 0.00USD 0SEC 申报 ↗
2026-02-20Cvijic Christine Mikail奖励／授予 (A)Common Stock22,000USD 0.00USD 0SEC 申报 ↗
2026-02-20Cobb Stuart奖励／授予 (A)Common Stock16,500USD 0.00USD 0SEC 申报 ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

快照与身份

快照日期2026-10-18
排名版本US-v1.2
数据质量PASS ELIGIBLE · —
股票代码NGNE
CIK0001404644
行业Healthcare
细分行业Biotechnology Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
交易所Nasdaq

数据覆盖

本地 Form 4 历史110 transaction lines from 2020-03-27 to 2026-09-22
33 P purchase lines · 56 S sale lines · 21 other lines
SEC 公司申报打开 SEC 申报 ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.